Companies: 10,795·Total market cap: $144.5T
Avisa Diagnostics Inc.

Avisa Diagnostics Inc.

FOGCFOTCHealthcare
$0.00
+$0.00(+0.00%)
Market Cap$97176
P/E Ratio
52W High$0.00001
52W Low$0.000001

Avisa Diagnostics Inc. (FOGCF) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

fogcf · pe ratio · data through Dec 31, 2020

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Avisa Diagnostics Inc. (FOGCF) measures how much investors pay for each dollar of the company's trailing earnings. FOGCF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.14.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2020-12-31

Forward P/E
N/A
EPS (TTM)
-$0.14
TTM · diluted EPS
PEG Ratio
0.00
Below 1.0 · Growth adjusted
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Avisa Diagnostics Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2019 – 2020 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Medical - Pharmaceuticals · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Avisa Diagnostics Inc.
Avisa Diagnostics Inc.You
FOGCF
$0MN/A-$0.14
Beijing Tong Ren Tang Chinese Medicine Company Limited
Beijing Tong Ren Tang Chinese Medicine Company Limited
BJTRF
$536M10.64x-77.9%$0.47
Basilea Pharmaceutica AG
Basilea Pharmaceutica AG
BPMUF
$806M15.24x-68.3%$3.29
PolyNovo Limited
PolyNovo Limited
CALZF
$415M64.01x+33.0%$0.02
Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals, Inc.
ELTP
$401MN/A-$0.00
ManifestSeven Holdings Corporation
ManifestSeven Holdings Corporation
MNFSF
$0MN/A-$0.78
Swedencare AB (publ)
Swedencare AB (publ)
SWDCF
$416M102.60x+113.2%$0.35
Industry Average
4 peers with valid PE
48.12xbaseline

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 2 of 2 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2020-12-31Latest
FY2020
$-0.14
2019-12-31
FY2019
$-0.84

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Avisa Diagnostics Inc. (FOGCF) measures how much investors pay for each dollar of the company's trailing earnings. FOGCF's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.14.

PE Ratio = Stock Price ÷ EPS (TTM)
= $0.00 ÷ -$0.14 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

FOGCF pe ratio · 6 questions

FOGCF's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.14. Data sourced from Financial Modeling Prep via FOGCF's SEC 10-K and 10-Q filings.

FOGCF PE ratioWhat is FOGCF PE ratioCurrent PE ratio of FOGCFFOGCF PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Avisa Diagnostics Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09